+ All Categories

Home > Documents > OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH...

OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH...

Date post:	01-Jun-2020
Category:	Documents
Upload:	others
View:	2 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

24

Transcript

Page 1: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 2: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 3: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 4: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 5: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 6: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 7: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 8: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 9: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 10: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

81% (2 steps)

Page 11: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 12: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 13: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 14: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Ns = S

O

O

O2N

Page 15: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

H

H

H

H H

H

H+

R

O

OH

O

O

OHR

H+

H Oxidation

+H2O

H+

R

R

H

CO2

Page 16: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 17: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 18: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

OTBDPS

OBnOBn

OBn

OTBDPS

OBnOBn

OBn

OBn

OBn

OBn

OBn

Page 19: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

OBn

OBn

OBn

OBn

OBn

Page 20: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

O

O

HO

OH

OH

A C

B

Page 21: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 22: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 23: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Page 24: OS0nR¹s v T b e¹lÕ - JST · Med. Chem. Lett., 17, 3095(2007) Target molecule O OH OH OH O O OH OH OH Å eO^x0 Säu0 ]ç0 4g( ÿ ry X2006-350249 Linker Biotin Fluorescent (Tokyo

Recommended

soils.landcareresearch.co.nz · Ohao Pt Parengarenga Har Great Exhibition Bay c ouhora Karikari Rangaunu . Bay 10 Oh Oh Oh Oh Oh Oh Motunau Oh Oh Oh Oh O White I Oh Oh CEA Oh xxxx

Cambridge International Examinations Cambridge ... · CH 2 OH OH O OH CH 2 OH OH HO O O OH CH 2 OH OH O O OH OH CH 2 OH OH Which procedures could be carried out in order to test for

HO O O HO OUnit 2 H O OH OH Nature's Chemistry

Metabolismo do Glicogênio - dracena.unesp.br fileMetabolismo do Glicogênio. H O OH H H OH OH CH2OH H O H H H OH OH CH2OH H O H H H O O H H OH OH CH2 H H H O H ... glycogen phosphorylase

HO H OH Chase Bruggeman O OH H OH - Chemistry...CEM 852 Presentation. 4/11/2020. 1 O OH HO H OH OH O H Luo et al. JACS 2019, 141, 20048 (–)-Oridonin • Biological activity: •

oh ooh h oh w oh b. w oh b. - Eastern Health · KAREN Eastern Health 2007 BASICS tD rdm w oh b. NO SMOKING / NO / w oh b. w oh b. YES / oh ooh h oh UNSURE / u oH. o &. /o &. rk.rrkk..rk.

Pompeii - korinor · SOPRANO ALTO TENOR BASS = 128 xxo Eh Eh e e xxa Pompeii o, o, eh eh Words and Music by Dan Smith o, o, oh oh oh oh o, o, eh eh eh eh eh eh oh

1.qigroup.nibs.ac.cn/wp-content/uploads/2019/10/Cum-10...neo 9C!q neo gqqugou neo OH OH [01 neo Slqol neo All_JÀloaone D!GCOXISUU HSo HOOC.„, OH HO neo OH OH [o] o neo OH o (2+5)

CharacterisationofFlavonoidAglyconesbyNegativeIon Chip ... · 2011. 9. 26. · 2 International Journal of Analytical Chemistry HO OH O O R1 R2 R3 R4 OH OH OH OH OH OH OH R1 R2 R3

O.Fri IováandM.Koval akovádownloads.hindawi.com/archive/2013/248164.pdf · ISRN Analytical Chemistry CH 2 OH 1 2 3 4 5 6 O O OH n m OH CH 2-1, 6-1, 3 OH OH 1 2 3 4 5 6 O O OH 1

FluorescencePolarizationBindingAssayforAspergillus ...2 Enzyme Research OH OH OH OH OH OH OH OHOH N N N NH H HO PP P P O O O O O O O O O O O O O O HO HO HO UDP-Galp UDP-Galf AfUGM

Controlling the Surface Properties of Nanoparticles ... · 1. Core-Shell Nanoparticles O Si O O OEt Et Et Et OH-Hydrolysis Condensation-H 20 O Si O O OH H H H Si OH O O O Amorphous

Basic Review of Growth Modelshaiyunc/notes/Econ 809 Notes.pdfEcon 809 Macro Jan 13, 2011 Page 6 of 54 ä ç % ç0 ñ ç - ç > 50 ã ç0, ä ç0, ñ ç0 Note that these are only the

Baran Group Meeting JACS: 1987 A Year in Review Dane Holte · Baran Group Meeting JACS: 1987 A Year in Review Dane Holte O O Me Me HO Me O OH OH OH OH OH OH CO 2H O Stereocontrolled

University of Liege presentatio… · Luzuriaga-Loaiza Deleuet al., Sci. Reports, 8, 8534 (2018) (2019) Elicitors OH OH OH OH OH OH HO HO O O O O O H O O OH O O SO 3 Na O O OH OH

EffectivenessoftheNovelHerbalMedicine,KIOM-MA,and … · 2019. 7. 31. · 4 Evidence-Based Complementary and Alternative Medicine O CH2OH CH2OH CH2OH O OH OH OH OH OH OH OH HO HO

UseofAntimonyintheTreatmentofLeishmaniasis ...MolecularBiologyInternational 3 OH OH OH OH OH OH OH OH HO HO HO O O O O O O HN Sb 364 Da 365 Da O− Sb− Figure 1: Proposed structural

MUC1 glycopeptide based anti- cancer vaccines...O OH HO OH HO O O OH OH HO O OH HO O HO H 4 α-Gal Conjugate Vaccines • Immunogenicity against HIV gp120 was increased >100 fold by